文献速递心胸血管麻醉神经外科与老年麻醉

神经元损伤生物标志物预测心脏手术后长期认知功能障碍

Neuronal damage biomarkers in the identification of patients at risk of long-term postoperative cognitive dysfunction after cardiac surgery.
PubMed 文献 · Anaesthesia · 2016-12-17

研究探讨经典神经元损伤标志物(脑脂肪酸结合蛋白、神经元特异性烯醇化酶、S100β)及血浆游离血红蛋白能否预测冠状动脉旁路移植术后长期认知下降。术后3个月57例中15例(26%)出现认知下降,15个月48例中13例(27%)。15个月认知障碍患者术前脑脂肪酸结合蛋白已显著升高,而经典神经元损伤标志物无明确预后价值。

要点

  • 术前脑脂肪酸结合蛋白升高与15个月认知功能障碍相关
  • 术后3个月认知功能障碍是15个月认知下降的预后因素
  • 经典神经元损伤标志物对长期认知下降无明确预测价值

核心结论

  • 脑脂肪酸结合蛋白在术前及整个术后期间在15个月认知下降患者中持续显著升高。
  • 经典神经元损伤相关标志物对长期认知下降无明确预后价值。
  • 术后3个月认知功能障碍与15个月认知下降相关,是术后一年个体认知表现下降的有价值预后因素。

研究设计与样本

  • 评估冠状动脉旁路移植术(伴或不伴体外循环)后患者认知功能的前瞻性研究。
  • 使用CogState简要计算机化认知测试组合在术后3个月和15个月评估认知功能。
  • 术前、关胸后、术后6小时和24小时采集血样。

主要发现

  • 术后3个月57例中15例(26%)出现认知下降,15个月48例中13例(27%)出现认知下降。
  • 15个月认知障碍患者术前脑脂肪酸结合蛋白水平为22.8(8.3-33.0 [0-44.6])pg.ml-1,无认知障碍患者为9.7(3.9-17.3 [0-49.0])pg.ml-1。
  • 术后3个月时,关胸时高血浆游离血红蛋白与认知表现负相关。
  • 神经心理测试高基线评分对认知表现有负面影响,而较高教育水平对认知结果有益。

临床怎么用

  • 术前可检测脑脂肪酸结合蛋白以识别心脏手术后长期认知下降高风险患者。
  • 术后3个月认知功能评估有助于预测术后15个月认知下降。
  • 经典神经元损伤标志物不推荐用于预测心脏手术后长期认知下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Biomarkers of neurological injury can potentially predict postoperative cognitive dysfunction. We aimed to identify whether classical neuronal damage-specific biomarkers, including brain fatty acid-binding protein, neuron-specific enolase and S100 calcium-binding protein β, as well as plasma-free haemoglobin concentration as a measure of haemolysis, could be used to predict the risk of long-term cognitive decline after coronary artery bypass grafting with or without cardiopulmonary bypass. We assessed cognitive function using the CogState brief computerised cognitive test battery at 3 months and at 15 months after surgery. Blood samples were obtained pre-operatively, after sternal closure, and at 6 h and 24 h postoperatively. We found signs of cognitive decline at 3 months in 15 of 57 patients (26%), and in 13 of 48 patients (27%) at 15 months. Brain fatty acid-binding protein was already significantly higher before surgery in patients with postoperative cognitive dysfunction at 15 months, with pre-operative plasma levels of 22.8 (8.3-33.0 [0-44.6]) pg.ml-1 compared with 9.7 (3.9-17.3 [0-49.0]) pg.ml-1 in patients without cognitive dysfunction. This biomarker remained significantly higher in patients with cognitive decline throughout the entire postoperative period. At 3 months after surgery, high levels of plasma-free haemoglobin at sternal closure were associated with a negative influence on cognitive performance, as were high baseline scores on neuropsychological tests, whereas a higher level of education proved to beneficially influence cognitive outcome. We found that postoperative cognitive dysfunction at 3 months was associated with cognitive decline at 15 months after surgery, and served as a valuable prognostic factor for declines in individual cognitive performance one year later. Classical neuronal injury-related biomarkers were of no clear prognostic value.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Kok WF, Koerts J, Tucha O, et al. Neuronal damage biomarkers in the identification of patients at risk of long-term postoperative cognitive dysfunction after cardiac surgery. Anaesthesia. 2016. PMID: 27987229. doi:10.1111/anae.13712

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。